Skip to content
akaturk Academic measurement

Article detail · 2025 · article

Idiopathic Granulomatous Mastitis: A Consensus Report on Treatment and Follow-Up Approaches Based on the Turkish Clinical Classification

Journal Breast Care
ISSN1661-3791
YÖKSİS OpenAlex Open access · green
Year2025
Citations2OpenAlex
Percentile%76.6
FWCI1.261.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q2

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueBreast Care
  • Catalog match (ISSN)Breast Care
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

Objective: The second consensus study on idiopathic granulomatous mastitis (IGM) aimed to establish treatment options based on the clinical classification proposed in the first consensus, standardize criteria for treatment discontinuation, and develop follow-up protocols. Method: A structured methodology, identical to the first consensus study, was employed. An 11-member working group of breast surgeons experienced in IGM from various clinics across the country was formed. The modified Delphi method was used, with a consensus threshold of 80% agreement. Results: Three voting rounds were conducted to develop the IGM treatment algorithm. In Round 1, observation was established as the first-line option for Type 1 disease (81%) and pregnancy/lactation cases (85%). Round 2 achieved consensus on systemic steroids (SS) as the first-line treatment for Type 3 cases (84%), combination therapies for resistant cases (82%), and reclassification of recurrent cases to guide treatment planning (94%). In Round 3, consensus was reached on the use of immunosuppressive therapy (IMT) for cases where steroids are contraindicated in Type 3 (81%), the use of IMT for resistant cases (93%), avoiding surgery as the first-line option for Type 1 cases (81%), and requiring complete clinical and radiological response before discontinuing treatment (81%). However, no consensus was reached on the first-line treatment for Type 2 disease. Conclusion: This consensus study successfully developed a treatment algorithm for IGM, prioritizing observation for Type 1 disease and cases involving pregnancy or lactation, and recommending systemic steroids (SS) and immunosuppressive therapies for Type 3 cases. The findings underscore the critical importance of achieving complete clinical and radiological remission before discontinuing treatment. However, the lack of consensus on the treatment of Type 2 disease highlights the need for further research into this challenging subtype.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

2citationsOpenAlex · cited_by_count (cache / database)

4 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2025 Decreased Serum and Tissue Levels of Isthmin‐1 in Patients With Idiopathic Granulomatous Mastitis: A Case–Control StudyCitations 0 · OpenAlex
  2. 2025 Decreased Serum and Tissue Levels of Isthmin‐1 in Patients With Idiopathic Granulomatous Mastitis: A Case–Control StudyCitations 0 · OpenAlex
  3. 2025 Decreased Serum and Tissue Levels of Isthmin‐1 in Patients With Idiopathic Granulomatous Mastitis: A Case–Control StudyCitations 0 · OpenAlex
  4. 2025 Decreased Serum and Tissue Levels of Isthmin‐1 in Patients With Idiopathic Granulomatous Mastitis: A Case–Control StudyCitations 0 · OpenAlex

Authors

12
  1. MUSTAFA EMİROĞLU 1
  2. KENAN ÇETİN 2
  3. KERİM BORA YILMAZ 3
  4. MEHMET VELİDEDEOĞLU 4
  5. SADULLAH GİRGİN 5
  6. FATİH ALPER AKCAN 6
  7. HÜSEYİN ÖZGÜR AYTAÇ 7
  8. MURAT AKIN 8
  9. HANDE KÖKSAL 9
  10. NESLİHAN CABIOĞLU İSTANBUL ÜNİVERSİTESİ 10
  11. NUH ZAFER CANTÜRK 11
  12. MAHMUT BAHADIR GÜLLÜOĞLU 12